Showing results (31-40 of 129) with videos related to
Sort By:
Pageof 13
Leukemia & Lymphoma|May 10, 2021
Real-world evidence on survival, adverse events, and health care burden in Medicare patients with mantle cell lymphomaRavi K Goyal, Preetesh Jain, Saurabh P Nagar, et al.Leukemia & Lymphoma|May 25, 2019
Outcomes of patients with chronic phase chronic myeloid leukemia (CML-CP) after discontinuation of frontline ponatinib therapyPrajwal Boddu, Preetesh Jain, Gautam Borthakur, et al.Journal for Immunotherapy of Cancer|October 17, 2020
Management of a patient with mantle cell lymphoma who developed severe neurotoxicity after chimeric antigen receptor T-cell therapy in ZUMA-2Michael Wang, Preetesh Jain, T Linda Chi, et al.Cancer|July 22, 2014
FCR and bevacizumab treatment in patients with relapsed chronic lymphocytic leukemiaPreetesh Jain, Hun Ju Lee, Wei Qiao, et al.Cancer Genetics|December 25, 2022
Clinical impact of 5<sup>'</sup>MYC or 3<sup>'</sup>MYC gain/loss detected by FISH in patients with aggressive B-cell lymphomasGuilin Tang, Shaoying Li, Gokce A Toruner, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2016
Long-term Follow-up of Treatment with Ibrutinib and Rituximab in Patients with High-Risk Chronic Lymphocytic LeukemiaPreetesh Jain, Michael J Keating, William G Wierda, et al.Clinical Lymphoma, Myeloma & Leukemia|November 1, 2011
Monitoring of minimal residual disease in acute myeloid leukemia: methods and best applicationsJeffrey L Jorgensen, Su S ChenAmerican Journal of Hematology|February 17, 2015
High fluorescence in situ hybridization percentage of deletion 11q in patients with chronic lymphocytic leukemia is an independent predictor of adverse outcomePreetesh Jain, Michael Keating, Phillip A Thompson, et al.Leukemia & Lymphoma|February 22, 2018
Ibrutinib inhibits free fatty acid metabolism in chronic lymphocytic leukemiaUri Rozovski, David M Harris, Ping Li, et al.Immunologic Research|October 20, 2015
Identification and characterization of distinct IL-17F expression patterns and signaling pathways in chronic lymphocytic leukemia and normal B lymphocytesBarbara Sherry, Preetesh Jain, Pui Yan Chiu, et al.Pageof 13